Erectile Dysfunction Devices Market, by Device Type (Non-Surgical Devices (Vacuum Constriction Devices, Erectile Dysfunction Shockwave Generators, and External Penile Rigidity Devices) and Surgical Devices (Vacuum Constriction Devices (Inflatable Implants

Erectile Dysfunction Devices Market, by Device Type (Non-Surgical Devices (Vacuum Constriction Devices, Erectile Dysfunction Shockwave Generators, and External Penile Rigidity Devices) and Surgical Devices (Vacuum Constriction Devices (Inflatable Implants and Malleable (Semi-Rigid) Implants), and Other Surgical Devices)), by End User (Hospitals, Clinics, and Ambulatory Surgery Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Patients suffering from erectile dysfunction initially opt for non-surgical treatment options such as oral phosphodiesterase type-5 inhibitors (Viagra, Cialis, and others), injections, injections, suppositories, and penis pumps. However, if a patient fails to respond for all the above mentioned treatment then penile implant has found to be the most common option for men seeking treatment for erectile dysfunction. For instance, according to the Cleveland Clinic, a non-profit academic medical center based in Ohio, U.S., around 20,000 American men opt for a penis implant every year. Penile implants are becoming widely accepted treatment option in the U.S. which is anticipated to boost the market growth over the forecast period. Furthermore, according to the study published in the Translational Andrology and Urology in February 2021, around 85.9% of total 63,013 total penile implantation procedures were performed in the U.S. from 2005 to 2012.

Market Dynamics

The rising prevalence of erectile dysfunction mandates the need to launch various awareness campaigns to focus on the treatment of this condition. Several manufacturers such as Pfizer are focusing on launching campaigns regarding erectile dysfunction. Some noteworthy examples are European impotence awareness campaign and unbranded erectile dysfunction awareness campaign aiming at younger men. For instance, in the U.S., February 14 is considered as a National Impotence Day, where the government and healthcare workers create awareness about erectile dysfunction, its causes, and the available treatment options for erectile dysfunction. Moreover, they also focus on the types of erectile dysfunction and how it affects the mental health.
Furthermore, several market players commercialize various technologically advanced non-invasive devices for the treatment of erectile dysfunction, which is expected to boost the market growth over the forecast period. For instance, Vertica is a non-invasive home use medical device designed to enhance erectile quality, which is manufactured by OHH-MED Medical Ltd., a medical device company.

Key features of the study:
This report provides an in-depth analysis of global erectile dysfunction devices market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global erectile dysfunction devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Boston Scientific Corporation, Coloplast Corp., Zephyr Surgical Implants, Owen Mumford Ltd., Augusta Medical Systems, Storz medical AG, Promedon, The Elator, Timm Medical, and Silimed
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global erectile dysfunction devices market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global erectile dysfunction devices market
Detailed Segmentation:
Global Erectile Dysfunction Devices Market, By Device Type:
Non-Surgical Devices
Vacuum Constriction Devices
Erectile Dysfunction Shockwave Generators
External Penile Rigidity Devices
Surgical Devices
Vacuum Constriction Devices
Inflatable Implants
Malleable (Semi-Rigid) Implants
Other Surgical Devices
Global Erectile Dysfunction Devices Market, By End User:
Hospitals
Clinics
Ambulatory Surgery Centers
Global Erectile Dysfunction Devices Market, By Region:
North America
By Device Type:
Non-Surgical Devices
Vacuum Constriction Devices
Erectile Dysfunction Shockwave Generators
External Penile Rigidity Devices
Surgical Devices
Penile Implants
Inflatable Implants
Malleable (Semi-Rigid) Implants
Other Surgical Devices
By End User:
Hospitals
Clinics
Ambulatory Surgery Centers
By Country:
U.S.
Canada
Latin America
By Device Type:
Non-Surgical Devices
Vacuum Constriction Devices
Erectile Dysfunction Shockwave Generators
External Penile Rigidity Devices
Surgical Devices
Penile Implants
Inflatable Implants
Malleable (Semi-Rigid) Implants
Other Surgical Devices
By End User:
Hospitals
Clinics
Ambulatory Surgery Centers
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Device Type:
Non-Surgical Devices
Vacuum Constriction Devices
Erectile Dysfunction Shockwave Generators
External Penile Rigidity Devices
Surgical Devices
Penile Implants
Inflatable Implants
Malleable (Semi-Rigid) Implants
Other Surgical Devices
By End User:
Hospitals
Clinics
Ambulatory Surgery Centers
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
Asia Pacific
By Device Type:
Non-Surgical Devices
Vacuum Constriction Devices
Erectile Dysfunction Shockwave Generators
External Penile Rigidity Devices
Surgical Devices
Penile Implants
Inflatable Implants
Malleable (Semi-Rigid) Implants
Other Surgical Devices
By End User:
Hospitals
Clinics
Ambulatory Surgery Centers
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific

Middle East
By Device Type:
Non-Surgical Devices
Vacuum Constriction Devices
Erectile Dysfunction Shockwave Generators
External Penile Rigidity Devices
Surgical Devices
Penile Implants
Inflatable Implants
Malleable (Semi-Rigid) Implants
Other Surgical Devices
By End User:
Hospitals
Clinics
Ambulatory Surgery Centers
By Country:
GCC
Israel
Rest of Middle East
Africa
By Device Type:
Non-Surgical Devices
Vacuum Constriction Devices
Erectile Dysfunction Shockwave Generators
External Penile Rigidity Devices
Surgical Devices
Penile Implants
Inflatable Implants
Malleable (Semi-Rigid) Implants
Other Surgical Devices
By End User:
Hospitals
Clinics
Ambulatory Surgery Centers
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Boston Scientific Corporation*
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Coloplast Corp.
Zephyr Surgical Implants
Owen Mumford Ltd.
Augusta Medical Systems
Storz medical AG
Promedon
The Elator
Timm Medical
Silimed

“*” marked represents similar segmentation in other categories in the respective section.